aluates Reports

$ 0.0

Automative

Global Injectable HIV Treatment Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-7M18651

BUY CHAPTERS

Global Injectable HIV Treatment Market Research Report 2024

Code: QYRE-Auto-7M18651

Report

October 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ViiV Healthcare

Janssen Pharmaceuticals

Gilead Sciences

Theratechnologies

Injectable HIV Treatment Market

Injectable HIV treatment refers to long-acting antiretroviral therapies administered through injection, designed to either treat or prevent HIV infection. The most notable example is the combination of cabotegravir and rilpivirine, which is administered once every one or two months for people living with HIV. Another injectable medication, cabotegravir alone, is used for Pre-Exposure Prophylaxis (PrEP) to prevent HIV infection in at-risk individuals.

The global Injectable HIV Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Injectable HIV Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Injectable HIV Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Injectable HIV Treatment include ViiV Healthcare, Janssen Pharmaceuticals, Gilead Sciences, Theratechnologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable HIV Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable HIV Treatment.

The Injectable HIV Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Injectable HIV Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable HIV Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Injectable HIV Treatment Market Report

Report Metric	Details
Report Name	Injectable HIV Treatment Market
Segment by Type	Cabotegravir Rilpivirine Lenacapavir Ibalizumab Other
Segment by Application	Pre-Exposure Prophylaxis HIV Treatment
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	ViiV Healthcare, Janssen Pharmaceuticals, Gilead Sciences, Theratechnologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable HIV Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable HIV Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Injectable HIV Treatment Market report?

Ans: The main players in the Injectable HIV Treatment Market are ViiV Healthcare, Janssen Pharmaceuticals, Gilead Sciences, Theratechnologies

What are the Application segmentation covered in the Injectable HIV Treatment Market report?

Ans: The Applications covered in the Injectable HIV Treatment Market report are Pre-Exposure Prophylaxis, HIV Treatment

What are the Type segmentation covered in the Injectable HIV Treatment Market report?

Ans: The Types covered in the Injectable HIV Treatment Market report are Cabotegravir, Rilpivirine, Lenacapavir, Ibalizumab, Other

Recommended Reports

HIV & AIDS Drugs

HIV Therapeutics

Drug Delivery Devices

1 Injectable HIV Treatment Market Overview

1.1 Product Definition

1.2 Injectable HIV Treatment by Type

1.2.1 Global Injectable HIV Treatment Market Value Comparison by Type (2024-2030)

1.2.2 Cabotegravir

1.2.3 Rilpivirine

1.2.4 Lenacapavir

1.2.5 Ibalizumab

1.2.6 Other

1.3 Injectable HIV Treatment by Application

1.3.1 Global Injectable HIV Treatment Market Value by Application (2024-2030)

1.3.2 Pre-Exposure Prophylaxis

1.3.3 HIV Treatment

1.4 Global Injectable HIV Treatment Market Size Estimates and Forecasts

1.4.1 Global Injectable HIV Treatment Revenue 2019-2030

1.4.2 Global Injectable HIV Treatment Sales 2019-2030

1.4.3 Global Injectable HIV Treatment Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Injectable HIV Treatment Market Competition by Manufacturers

2.1 Global Injectable HIV Treatment Sales Market Share by Manufacturers (2019-2024)

2.2 Global Injectable HIV Treatment Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Injectable HIV Treatment Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Injectable HIV Treatment, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Injectable HIV Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Injectable HIV Treatment, Product Type & Application

2.7 Global Key Manufacturers of Injectable HIV Treatment, Date of Enter into This Industry

2.8 Global Injectable HIV Treatment Market Competitive Situation and Trends

2.8.1 Global Injectable HIV Treatment Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Injectable HIV Treatment Players Market Share by Revenue

2.8.3 Global Injectable HIV Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Injectable HIV Treatment Market Scenario by Region

3.1 Global Injectable HIV Treatment Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Injectable HIV Treatment Sales by Region: 2019-2030

3.2.1 Global Injectable HIV Treatment Sales by Region: 2019-2024

3.2.2 Global Injectable HIV Treatment Sales by Region: 2025-2030

3.3 Global Injectable HIV Treatment Revenue by Region: 2019-2030

3.3.1 Global Injectable HIV Treatment Revenue by Region: 2019-2024

3.3.2 Global Injectable HIV Treatment Revenue by Region: 2025-2030

3.4 North America Injectable HIV Treatment Market Facts & Figures by Country

3.4.1 North America Injectable HIV Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Injectable HIV Treatment Sales by Country (2019-2030)

3.4.3 North America Injectable HIV Treatment Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Injectable HIV Treatment Market Facts & Figures by Country

3.5.1 Europe Injectable HIV Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Injectable HIV Treatment Sales by Country (2019-2030)

3.5.3 Europe Injectable HIV Treatment Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable HIV Treatment Market Facts & Figures by Region

3.6.1 Asia Pacific Injectable HIV Treatment Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Injectable HIV Treatment Sales by Region (2019-2030)

3.6.3 Asia Pacific Injectable HIV Treatment Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Injectable HIV Treatment Market Facts & Figures by Country

3.7.1 Latin America Injectable HIV Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Injectable HIV Treatment Sales by Country (2019-2030)

3.7.3 Latin America Injectable HIV Treatment Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Injectable HIV Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable HIV Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Injectable HIV Treatment Sales by Country (2019-2030)

3.8.3 Middle East and Africa Injectable HIV Treatment Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Injectable HIV Treatment Sales by Type (2019-2030)

4.1.1 Global Injectable HIV Treatment Sales by Type (2019-2024)

4.1.2 Global Injectable HIV Treatment Sales by Type (2025-2030)

4.1.3 Global Injectable HIV Treatment Sales Market Share by Type (2019-2030)

4.2 Global Injectable HIV Treatment Revenue by Type (2019-2030)

4.2.1 Global Injectable HIV Treatment Revenue by Type (2019-2024)

4.2.2 Global Injectable HIV Treatment Revenue by Type (2025-2030)

4.2.3 Global Injectable HIV Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Injectable HIV Treatment Price by Type (2019-2030)

5 Segment by Application

5.1 Global Injectable HIV Treatment Sales by Application (2019-2030)

5.1.1 Global Injectable HIV Treatment Sales by Application (2019-2024)

5.1.2 Global Injectable HIV Treatment Sales by Application (2025-2030)

5.1.3 Global Injectable HIV Treatment Sales Market Share by Application (2019-2030)

5.2 Global Injectable HIV Treatment Revenue by Application (2019-2030)

5.2.1 Global Injectable HIV Treatment Revenue by Application (2019-2024)

5.2.2 Global Injectable HIV Treatment Revenue by Application (2025-2030)

5.2.3 Global Injectable HIV Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Injectable HIV Treatment Price by Application (2019-2030)

6 Key Companies Profiled

6.1 ViiV Healthcare

6.1.1 ViiV Healthcare Company Information

6.1.2 ViiV Healthcare Description and Business Overview

6.1.3 ViiV Healthcare Injectable HIV Treatment Sales, Revenue and Gross Margin (2019-2024)

6.1.4 ViiV Healthcare Injectable HIV Treatment Product Portfolio

6.1.5 ViiV Healthcare Recent Developments/Updates

6.2 Janssen Pharmaceuticals

6.2.1 Janssen Pharmaceuticals Company Information

6.2.2 Janssen Pharmaceuticals Description and Business Overview

6.2.3 Janssen Pharmaceuticals Injectable HIV Treatment Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Janssen Pharmaceuticals Injectable HIV Treatment Product Portfolio

6.2.5 Janssen Pharmaceuticals Recent Developments/Updates

6.3 Gilead Sciences

6.3.1 Gilead Sciences Company Information

6.3.2 Gilead Sciences Description and Business Overview

6.3.3 Gilead Sciences Injectable HIV Treatment Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Gilead Sciences Injectable HIV Treatment Product Portfolio

6.3.5 Gilead Sciences Recent Developments/Updates

6.4 Theratechnologies

6.4.1 Theratechnologies Company Information

6.4.2 Theratechnologies Description and Business Overview

6.4.3 Theratechnologies Injectable HIV Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Theratechnologies Injectable HIV Treatment Product Portfolio

6.4.5 Theratechnologies Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable HIV Treatment Industry Chain Analysis

7.2 Injectable HIV Treatment Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable HIV Treatment Production Mode & Process

7.4 Injectable HIV Treatment Sales and Marketing

7.4.1 Injectable HIV Treatment Sales Channels

7.4.2 Injectable HIV Treatment Distributors

7.5 Injectable HIV Treatment Customers

8 Injectable HIV Treatment Market Dynamics

8.1 Injectable HIV Treatment Industry Trends

8.2 Injectable HIV Treatment Market Drivers

8.3 Injectable HIV Treatment Market Challenges

8.4 Injectable HIV Treatment Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

ViiV Healthcare

Janssen Pharmaceuticals

Gilead Sciences

Theratechnologies

List of Tables

Table 1. Global Injectable HIV Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Injectable HIV Treatment Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Injectable HIV Treatment Market Competitive Situation by Manufacturers in 2023

Table 4. Global Injectable HIV Treatment Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Injectable HIV Treatment Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Injectable HIV Treatment Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Injectable HIV Treatment Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Injectable HIV Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Injectable HIV Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Injectable HIV Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Injectable HIV Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Injectable HIV Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Injectable HIV Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable HIV Treatment as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Injectable HIV Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Injectable HIV Treatment Sales by Region (2019-2024) & (K Units)

Table 18. Global Injectable HIV Treatment Sales Market Share by Region (2019-2024)

Table 19. Global Injectable HIV Treatment Sales by Region (2025-2030) & (K Units)

Table 20. Global Injectable HIV Treatment Sales Market Share by Region (2025-2030)

Table 21. Global Injectable HIV Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Injectable HIV Treatment Revenue Market Share by Region (2019-2024)

Table 23. Global Injectable HIV Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Injectable HIV Treatment Revenue Market Share by Region (2025-2030)

Table 25. North America Injectable HIV Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Injectable HIV Treatment Sales by Country (2019-2024) & (K Units)

Table 27. North America Injectable HIV Treatment Sales by Country (2025-2030) & (K Units)

Table 28. North America Injectable HIV Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Injectable HIV Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Injectable HIV Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Injectable HIV Treatment Sales by Country (2019-2024) & (K Units)

Table 32. Europe Injectable HIV Treatment Sales by Country (2025-2030) & (K Units)

Table 33. Europe Injectable HIV Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Injectable HIV Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Injectable HIV Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Injectable HIV Treatment Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Injectable HIV Treatment Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Injectable HIV Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Injectable HIV Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Injectable HIV Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Injectable HIV Treatment Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Injectable HIV Treatment Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Injectable HIV Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Injectable HIV Treatment Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Injectable HIV Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Injectable HIV Treatment Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Injectable HIV Treatment Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Injectable HIV Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Injectable HIV Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Injectable HIV Treatment Sales (K Units) by Type (2019-2024)

Table 51. Global Injectable HIV Treatment Sales (K Units) by Type (2025-2030)

Table 52. Global Injectable HIV Treatment Sales Market Share by Type (2019-2024)

Table 53. Global Injectable HIV Treatment Sales Market Share by Type (2025-2030)

Table 54. Global Injectable HIV Treatment Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Injectable HIV Treatment Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Injectable HIV Treatment Revenue Market Share by Type (2019-2024)

Table 57. Global Injectable HIV Treatment Revenue Market Share by Type (2025-2030)

Table 58. Global Injectable HIV Treatment Price (US$/Unit) by Type (2019-2024)

Table 59. Global Injectable HIV Treatment Price (US$/Unit) by Type (2025-2030)

Table 60. Global Injectable HIV Treatment Sales (K Units) by Application (2019-2024)

Table 61. Global Injectable HIV Treatment Sales (K Units) by Application (2025-2030)

Table 62. Global Injectable HIV Treatment Sales Market Share by Application (2019-2024)

Table 63. Global Injectable HIV Treatment Sales Market Share by Application (2025-2030)

Table 64. Global Injectable HIV Treatment Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Injectable HIV Treatment Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Injectable HIV Treatment Revenue Market Share by Application (2019-2024)

Table 67. Global Injectable HIV Treatment Revenue Market Share by Application (2025-2030)

Table 68. Global Injectable HIV Treatment Price (US$/Unit) by Application (2019-2024)

Table 69. Global Injectable HIV Treatment Price (US$/Unit) by Application (2025-2030)

Table 70. ViiV Healthcare Company Information

Table 71. ViiV Healthcare Description and Business Overview

Table 72. ViiV Healthcare Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. ViiV Healthcare Injectable HIV Treatment Product

Table 74. ViiV Healthcare Recent Developments/Updates

Table 75. Janssen Pharmaceuticals Company Information

Table 76. Janssen Pharmaceuticals Description and Business Overview

Table 77. Janssen Pharmaceuticals Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Janssen Pharmaceuticals Injectable HIV Treatment Product

Table 79. Janssen Pharmaceuticals Recent Developments/Updates

Table 80. Gilead Sciences Company Information

Table 81. Gilead Sciences Description and Business Overview

Table 82. Gilead Sciences Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Gilead Sciences Injectable HIV Treatment Product

Table 84. Gilead Sciences Recent Developments/Updates

Table 85. Theratechnologies Company Information

Table 86. Theratechnologies Description and Business Overview

Table 87. Theratechnologies Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Theratechnologies Injectable HIV Treatment Product

Table 89. Theratechnologies Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Injectable HIV Treatment Distributors List

Table 93. Injectable HIV Treatment Customers List

Table 94. Injectable HIV Treatment Market Trends

Table 95. Injectable HIV Treatment Market Drivers

Table 96. Injectable HIV Treatment Market Challenges

Table 97. Injectable HIV Treatment Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Injectable HIV Treatment

Figure 2. Global Injectable HIV Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Injectable HIV Treatment Market Share by Type: 2023 & 2030

Figure 4. Cabotegravir Product Picture

Figure 5. Rilpivirine Product Picture

Figure 6. Lenacapavir Product Picture

Figure 7. Ibalizumab Product Picture

Figure 8. Other Product Picture

Figure 9. Global Injectable HIV Treatment Market Value by Application (2024-2030) & (US$ Million)

Figure 10. Global Injectable HIV Treatment Market Share by Application: 2023 & 2030

Figure 11. Pre-Exposure Prophylaxis

Figure 12. HIV Treatment

Figure 13. Global Injectable HIV Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Injectable HIV Treatment Market Size (2019-2030) & (US$ Million)

Figure 15. Global Injectable HIV Treatment Sales (2019-2030) & (K Units)

Figure 16. Global Injectable HIV Treatment Average Price (US$/Unit) & (2019-2030)

Figure 17. Injectable HIV Treatment Report Years Considered

Figure 18. Injectable HIV Treatment Sales Share by Manufacturers in 2023

Figure 19. Global Injectable HIV Treatment Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest Injectable HIV Treatment Players: Market Share by Revenue in Injectable HIV Treatment in 2023

Figure 21. Injectable HIV Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global Injectable HIV Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Injectable HIV Treatment Sales Market Share by Country (2019-2030)

Figure 24. North America Injectable HIV Treatment Revenue Market Share by Country (2019-2030)

Figure 25. United States Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Injectable HIV Treatment Sales Market Share by Country (2019-2030)

Figure 28. Europe Injectable HIV Treatment Revenue Market Share by Country (2019-2030)

Figure 29. Germany Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Injectable HIV Treatment Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Injectable HIV Treatment Revenue Market Share by Region (2019-2030)

Figure 36. China Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Injectable HIV Treatment Sales Market Share by Country (2019-2030)

Figure 44. Mexico Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa Injectable HIV Treatment Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa Injectable HIV Treatment Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Injectable HIV Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Injectable HIV Treatment by Type (2019-2030)

Figure 54. Global Revenue Market Share of Injectable HIV Treatment by Type (2019-2030)

Figure 55. Global Injectable HIV Treatment Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Injectable HIV Treatment by Application (2019-2030)

Figure 57. Global Revenue Market Share of Injectable HIV Treatment by Application (2019-2030)

Figure 58. Global Injectable HIV Treatment Price (US$/Unit) by Application (2019-2030)

Figure 59. Injectable HIV Treatment Value Chain

Figure 60. Injectable HIV Treatment Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Long acting Anti HIV Drugs Market Research Report 2024

Global Parenteral PrEP Market Research Report 2024

Global Drugs for PrEP Market Research Report 2024

Global Long acting PrEP Market Research Report 2024

Global Enfuvirtide for Injection Market Research Report 2024

HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injectable Drug Delivery Market Research Report 2024

Global HIV Therapy Market Research Report 2025

Global Intravitreal Injectable Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Intravitreal IVT Injectables Market Insights Forecast to 2030

Implantable Drug Delivery Devices Market

Global Antiretroviral Agent Market Research Report 2024

Global Long acting Anti HIV Drug Market Research Report 2024

Integrase Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injectable Fertility Medications Market Research Report 2024

Global Pre Exposure Prophylaxis PrEP Market Research Report 2024

Global Injectable IVF Medications Market Research Report 2024

Global Bictegravir Market Research Report 2024

Global Tenofovir Fumarate Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions